Bruxism possibly induced by venlafaxine

Clinical Neuropharmacology

Volumn 32, Issue 2, 2009, Pages 111-112

  Alonso Navarro, Hortensia ^a   Martín Prieto, Manuela ^a   Ruiz Ezquerro, Juan José ^a   Jiménez Jiménez, Félix Javier ^b,c  

^a HOSPITAL VIRGEN DE LA CONCHA   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c Hospital Universitario del Sureste de Madrid   (Spain)

Author keywords

Adverse effects; Bruxism; Drug induced; Venlafaxine

Indexed keywords

BOTULINUM TOXIN; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARTICLE; BRUXISM; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DRUG MECHANISM; DRUG WITHDRAWAL; HUMAN; MALE; MASSETER MUSCLE; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; TEMPORALIS MUSCLE;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BRUXISM; CYCLOHEXANOLS; DEPRESSION; HUMANS; MALE; MIDDLE AGED;

EID: 67749108371     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31816a3519     Document Type: Article

References (18)

1. Jankovic JJ, Fahn S. Dystonic disorders. In: Jankovic JJ, Tolosa E, eds. Parkinson's Disease and Movement Disorders. 4th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2002:330-357.
2. Watts MW, Tan EK, Jankovic J. Bruxism and cranial-cervical dystonia: is there a relationship? Cranio 1999;17:196-201.
3. Van Zandijcke M, Marchau MM. Treatment of bruxism with botulinum toxin injections. J Neurol Neurosurg Psychiatry 1990;53:530.
4. Tan EK, Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc 2000;131:211-216.
5. Magee KR. Bruxism related to levodopa therapy. JAMA 1970; 214:147.
6. Micheli F, Fernandez Pardal M, Gatto M, et al. Bruxism secondary to chronic antidopaminergic drug exposure. Clin Neuropharmacol 1993;16:315-323.
7. Amir I, Hermesh H, Gavish A. Bruxism secondary to antipsychotic drug exposure: a positive response to propranolol. Clin Neuropharmacol 1997;20:86-89.
8. Ellison JM, Stanziani P. SSRI-associated nocturnal bruxism in four patients. J Clin Psychiatry 1993;54:432-434.
9. Bostwick JM, Jaffee MS. Buspirone as an antidote to SSRI-induced bruxism in 4 cases. J Clin Psychiatry 1999;60:857-860.
10. Romanelli F, Adler DA, Bungay KM. Possible paroxetine-induced bruxism. Ann Pharmacother 1996;30:1246-1248.
11. Kishi Y. Paroxetine-induced bruxism effectively treated with tandospirone. J Neuropsychiatry Clin Neurosci 2007;19:90-91.
12. Wise M. Citalopram-induced bruxism. Br J Psychiatry 2001;178:182.
13. See SJ, Tan EK. Severe amphetamine-induced bruxism: treatment with botulinum toxin. Acta Neurol Scand 2003;107:161-163.
14. Gara L, Roberts W. Adverse response to methylphenidate in combination with valproic acid. J Child Adolesc Psychopharmacol 2000;10:39-43.
15. Gerber PE, Lynd LD. Selective serotonin-reuptake inhibitorYinduced movement disorders. Ann Pharmacother 1998;32:692-698.
16. Chen Z, Skolnick P. Triple uptake inhibitors: therapeutic potential in depression and beyond. Expert Opin Investig Drugs 2007;16: 1365-1377.
17. Brown ES, Hong SC. Antidepressant-induced bruxism successfully treated with gabapentin. J Am Dent Assoc 1999;130: 1467-1469.
18. Jaffee MS, Bostwick JM. Buspirone as an antidote to venlafaxine-induced bruxism. Psychosomatics 2000;41:535-536.3